Cell size as a primary determinant in targeted nanoparticle uptake
dc.contributor.author | Howard, D | en_AU |
dc.contributor.author | Turnbull, T | en_AU |
dc.contributor.author | Paterson, DJ | en_AU |
dc.contributor.author | Thierry, B | en_AU |
dc.contributor.author | Kempson, I | en_AU |
dc.date.accessioned | 2024-12-20T02:00:21Z | en_AU |
dc.date.available | 2024-12-20T02:00:21Z | en_AU |
dc.date.issued | 2022-08-26 | en_AU |
dc.date.statistics | 2024-10-30 | en_AU |
dc.description.abstract | Nanoparticle (NP) internalization by cells is complex, highly heterogeneous, and fundamentally important for nanomedicine. We report powerful probabilistic statistics from single-cell data on quantitative NP uptake of PEG-coated transferrin receptor-targeted gold NPs for cancer-derived and fibroblast cells according to their cell size, receptor expression, and receptor density. The smaller cancer cells had a greater receptor density and more efficient uptake of targeted NPs. However, simply due to fibroblasts being larger with more receptors, they exhibited greater NP uptake. While highly heterogeneous, targeted NP uptake strongly correlated with receptor expression. When uptake was normalized to cell size, no correlation existed. Consequently, skewed population distributions in cell sizes explain the distribution in NP uptake. Furthermore, exposure to the transferrin receptor-targeted NPs alters the fibroblast size and receptor expression, suggesting that the receptor-targeted NPs may interfere with the metabolic flux and nutrient exchange, which could assist in explaining the altered regulation of cells exposed to nanoparticles. © 2022 American Chemical Society. | en_AU |
dc.description.sponsorship | This research was supported by the Australian Government through the Australian Research Council’s Discovery Projects funding scheme (project no. DP190102119); the X-ray Fluorescence Microscopy beamline at the Australian Synchrotron, part of ANSTO; and the facilities, scientific and technical assistance of Microscopy Australia, funded by the University of South Australia, State and Federal Governments. | en_AU |
dc.format.medium | Print-Electronic | en_AU |
dc.identifier.citation | Howard, D., Turnbull, T., Paterson, D. J., Thierry, B., & Kempson, I. (2022). Cell size as a primary determinant in targeted nanoparticle uptake. ACS Applied Bio Materials, 5(9), 4222-4231. doi:10.1021/acsabm.2c00434 | en_AU |
dc.identifier.issn | 2576-6422 | en_AU |
dc.identifier.issue | 9 | en_AU |
dc.identifier.journaltitle | ACS Applied Bio Materials | en_AU |
dc.identifier.pagination | 4222-4231 | en_AU |
dc.identifier.uri | https://doi.org/10.1021/acsabm.2c00434 | en_AU |
dc.identifier.uri | https://apo.ansto.gov.au/handle/10238/15845 | en_AU |
dc.identifier.volume | 5 | en_AU |
dc.language | English | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | American Chemical Society | en_AU |
dc.subject | Nanoparticles | en_AU |
dc.subject | Receptors | en_AU |
dc.subject | Gold | en_AU |
dc.subject | Fluorescence | en_AU |
dc.subject | Metabolic diseases | en_AU |
dc.subject | Nutrients | en_AU |
dc.subject | Receptors | en_AU |
dc.subject | Therapeutic doses | en_AU |
dc.title | Cell size as a primary determinant in targeted nanoparticle uptake | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1